About Immunocept Medical Products
Immunocept Medical Products is a company based in Denver (United States) founded in 1999 was acquired by CytoPherx in June 2018. Immunocept Medical Products has raised $530 thousand across 1 funding round from investors including CytoPherx. Immunocept Medical Products operates in a competitive market with competitors including Haemonetics, Vetex Medical, MediSieve, Immutrix Therapeutics and Hemostasis, among others.
- Headquarter Denver, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Immunocept Medical Products, Llc
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Immunocept Medical Products
Immunocept Medical Products has successfully raised a total of $530K through 1 strategic funding round. The most recent funding activity was a Unspecified round of $530 thousand completed in August 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Immunocept Medical Products
Immunocept Medical Products has secured backing from 1 investor. Prominent investors backing the company include CytoPherx.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Cytopheresis systems for inflammatory conditions
|
Locked | Locked | Locked |
Investor details for Immunocept Medical Products
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Immunocept Medical Products
Investment portfolio details for Immunocept Medical Products
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Immunocept Medical Products
Detailed financials for Immunocept Medical Products
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Immunocept Medical Products Comparisons
Peer comparison for Immunocept Medical Products
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Immunocept Medical Products
Immunocept Medical Products operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Haemonetics, Vetex Medical, MediSieve, Immutrix Therapeutics and Hemostasis, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Hematology products and solutions are provided for medical applications.
|
|
| Locked | Locked | Locked |
Catheters for venous clot management and removal are developed.
|
|
| Locked | Locked | Locked |
Magnetic therapy is developed to treat blood-borne diseases.
|
|
| Locked | Locked | Locked |
Blood cleansing treatment device
|
|
| Locked | Locked | Locked |
Develops and manufactures hemostatic products for surgical bleeding control and patient care.
|
Detailed competitors of Immunocept Medical Products
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Immunocept Medical Products
Complete news archive for Immunocept Medical Products
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Immunocept Medical Products
Immunocept Medical Products was founded in 1999 and raised its 1st funding round 18 years after it was founded.
Immunocept Medical Products is headquartered in Denver, United States. It is registered at Denver, Colorado, United States.
Immunocept Medical Products is a funded company, having raised a total of $530K across 1 funding round to date.
Immunocept Medical Products is a clinical stage medical device company with a platform blood filtration therapy for severe sepsis and other diseases of destructive inflammation.The company targets the 1B plus severe sepsis market. The company claims to have 11 US patents, finished clinical devices and IDE approval for our feasibility study. The SeptiFlux is a hollow fiber, very large-pore membrane blood filter that differs from other hemofilters because it is designed to remove a significant fraction of every type and size of inflammatory signal circulating in the blood.
Immunocept Medical Products's top competitors include Haemonetics, Vetex Medical and MediSieve.
Immunocept Medical Products has 1 investor. Key investors include CytoPherx.